Tdap is not a live vaccine. It contains no living bacteria or viruses of any kind. Tdap is made from inactivated bacterial toxins and protein fragments, which means it cannot cause the diseases it protects against: tetanus, diphtheria, or pertussis (whooping cough).
This distinction matters for people with weakened immune systems, pregnant women, and anyone who has been told to avoid live vaccines. Tdap is safe for all of these groups.
What Tdap Actually Contains
Each component of Tdap uses a different strategy, but none involve live organisms.
The tetanus and diphtheria portions are “toxoids.” The bacteria that cause these diseases produce harmful toxins, and vaccine manufacturers treat those toxins with chemicals to neutralize them. What remains is a toxoid: a molecule that looks enough like the original toxin to train your immune system but is completely unable to cause illness. When injected, your body learns to recognize and fight the real toxin if you’re ever exposed.
The pertussis portion takes a similar approach but uses purified protein fragments from the surface of the pertussis bacterium rather than a whole cell. This is why it’s called “acellular” pertussis. The current version of this acellular vaccine has been in use since 1996, replacing an older whole-cell version that caused more side effects. Today’s Tdap contains between two and five of these treated protein fragments, depending on the brand.
The two Tdap brands available in the United States are Adacel (Sanofi Pasteur) and Boostrix (GlaxoSmithKline). Both contain 5 Lf of tetanus toxoid and slightly different amounts of diphtheria toxoid and pertussis proteins, but neither contains anything alive.
Why the Live vs. Inactivated Distinction Matters
Live vaccines use a weakened form of a virus or bacterium that can still replicate in your body. Examples include the MMR vaccine, the chickenpox vaccine, and the nasal spray flu vaccine. These are highly effective but can pose risks for people with compromised immune systems, because even a weakened organism could cause problems when the body can’t mount a normal defense.
Inactivated vaccines like Tdap carry no such risk. The toxoids and protein fragments in Tdap cannot replicate, cannot spread to others, and cannot cause infection. This is why Tdap is specifically recommended during pregnancy, when live vaccines are generally avoided. The CDC recommends that pregnant women receive Tdap during the 27th through 36th week of each pregnancy, preferably in the earlier part of that window. The antibodies a mother produces cross the placenta and give the newborn some protection against whooping cough in the first weeks of life.
Tdap vs. DTaP: Same Diseases, Different Doses
You may have seen “DTaP” and wondered how it differs from Tdap. Both protect against the same three diseases using the same types of inactivated components. The difference is dosage and audience. DTaP contains higher concentrations of diphtheria and pertussis antigens and is given to children under 7 in a series of shots. Tdap uses lower doses of those same components (indicated by the lowercase “d” and “p”) and is designed for older children, teens, and adults as a booster. The capital “T” in both names reflects that the tetanus toxoid dose is the same.
Who Should Get Tdap and When
The standard recommendation is one dose of Tdap for anyone who hasn’t previously received it, followed by a Td or Tdap booster every 10 years. Most people first receive Tdap around age 11 or 12. Adults who never got that initial dose should get one as soon as possible, regardless of age.
Pregnant women are a special case. Because Tdap is not a live vaccine, it’s recommended during every pregnancy, not just the first. This timing ensures each baby gets the maximum transfer of protective antibodies before birth.
Tdap can also be given for wound management. If you show up at urgent care with a deep cut or puncture wound and it’s been more than five years since your last tetanus-containing vaccine, you’ll likely receive a dose.
Common Side Effects
Because Tdap doesn’t contain live organisms, the side effects reflect your immune system’s response to the inactivated components rather than any kind of infection. The most common reaction is soreness, redness, or swelling at the injection site. Some people experience a mild headache, fatigue, or low-grade fever for a day or two. These reactions are generally mild and resolve on their own.
The one serious contraindication specific to the pertussis component is a history of encephalopathy (brain swelling) within seven days of a previous dose, when no other cause can be identified. This is extremely rare. A severe allergic reaction to a previous dose of any tetanus, diphtheria, or pertussis vaccine is also a reason to avoid Tdap.